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Available online 17 April 2006Recent work has shown that the sequence of the peptide supplied by the company who synthesized the peptide, was not quite the
same as ordered and as appears in the paper. The peptide was supplied with an antibody to the E domain of the rat/mouse IGF-IEa.
Unbeknown to the authors a cysteine had been added to the C-terminal end of the peptide, presumably to make it more immuno-
genic. Therefore the peptide was not 24 amino acids as stated in the paper but 25 amino acids with cysteine on the C-terminus.q DOI of original article: 10.1016/S0014-5793(02)02918-6.
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